At CUSP we believe in providing the best quality of treatment for our patients
Expert Diagnosis, Personalised Treatment & Advanced Surgical Care at CUSP Group of Surgeons
Ovarian cancer is one of the most common gynaecological cancers and often develops silently, with symptoms appearing only in the later stages. It begins in the ovaries, the organs responsible for producing eggs and female hormones, and can spread to nearby organs or other parts of the abdomen if left untreated. Although ovarian cancer is challenging to detect early, advances in diagnostic techniques, surgery, and cancer therapies have significantly improved treatment outcomes.
CUSP Surgeons, is a team of highly experienced and skilled surgeons dedicated to delivering advanced surgical care with precision, safety, and compassion for cervical cancer. Every patient receives a personalised treatment plan developed by a multidisciplinary team, combining advanced diagnostics, specialised cancer surgery, chemotherapy, and supportive care to achieve the best possible outcomes while preserving quality of life.
What is Ovarian Cancer?
Ovarian cancer occurs when abnormal cells within one or both ovaries grow uncontrollably and form a tumour. The ovaries are part of the female reproductive system and play an important role in producing eggs and hormones such as oestrogen and progesterone.
The most common type is epithelial ovarian cancer, which arises from the outer surface of the ovary and accounts for the majority of cases. Less common types include germ cell tumours and stromal tumours, which usually affect younger women and require specialised treatment.
In its early stages, ovarian cancer is often confined to the ovaries. As the disease progresses, it may spread to the lining of the abdomen, lymph nodes, or other organs. Early diagnosis and timely treatment are essential for improving long-term outcomes.
What Causes Ovarian Cancer?
The exact cause of ovarian cancer is not fully understood. However, several factors are known to increase the risk of developing the disease.
Common risk factors include:
Having one or more of these risk factors does not necessarily mean a woman will develop ovarian cancer. However, women with a strong family history or inherited genetic conditions should discuss screening and risk assessment.
Why Early Diagnosis Matters
Ovarian cancer is often referred to as a “silent disease” because its early symptoms are vague and easily mistaken for common digestive or urinary conditions. As a result, many women are diagnosed only after the disease has spread beyond the ovaries.
What are the Symptoms of Ovarian Cancer?
Early ovarian cancer may cause few or no noticeable symptoms. As the tumour grows, women may experience:
These symptoms can also occur in many non-cancerous conditions. However, symptoms that persist for more than two to three weeks or become progressively worse should be evaluated by a specialist.
How is Ovarian Cancer Diagnosed?
Accurate diagnosis and staging are essential for determining the most appropriate treatment. At CUSP Group of Surgeons, diagnosis begins with a detailed medical history, pelvic examination, and advanced imaging to evaluate the ovaries and determine whether the disease has spread.
Diagnostic tests may include:
Early and accurate diagnosis enables personalised treatment planning and improves the chances of successful treatment.
Treatment Options for Ovarian Cancer
Treatment for ovarian cancer depends on several factors, including the type of ovarian cancer, its stage, the extent of spread, the patient’s age, overall health, and future fertility considerations. At CUSP, every treatment plan is developed through a multidisciplinary approach involving gynaecologic cancer surgeons, medical oncologists, radiologists, pathologists, and supportive care specialists to provide personalised, evidence-based treatment.
Surgery is the cornerstone of treatment for most ovarian cancers. The primary goal is to remove all visible cancer while preserving healthy tissue whenever possible and improving the effectiveness of additional treatments such as chemotherapy.
In selected patients with early-stage ovarian cancer or suspicious ovarian masses, laparoscopic or robotic-assisted surgery may be performed. These minimally invasive techniques use small incisions and specialised instruments, offering several advantages over traditional open surgery.
Potential benefits include:
The choice of surgical approach depends on the size of the tumour, stage of the disease, and current evidence-based treatment recommendations.
Chemotherapy is an important part of ovarian cancer treatment and is commonly used after surgery to destroy any remaining cancer cells and reduce the risk of recurrence.
It may also be recommended:
Targeted therapy uses medicines that specifically attack cancer cells by blocking the pathways responsible for tumour growth. These treatments are particularly beneficial for selected patients with BRCA gene mutations or other specific molecular characteristics.
Your treating team may recommend genetic and molecular testing to determine whether targeted therapy is appropriate as part of your treatment plan.
In selected cases of recurrent or advanced ovarian cancer, immunotherapy may be considered based on tumour biology and latest clinical evidence. These therapies aim to improve outcomes by enhancing the body’s immune response against cancer cells or targeting specific molecular pathways.
Comprehensive Follow-up & Survivorship Care
Regular follow-up is essential after ovarian cancer treatment to monitor recovery, detect any recurrence at an early stage, and address the long-term physical and emotional well-being of patients.
At CUSP Group of Surgeons, follow-up care includes periodic clinical evaluations, imaging when required, tumour marker assessment, nutritional guidance, and supportive care.
Cashless Treatment & Government Health Schemes
At CUSP Group of Surgeons & CUSP Cancer Care, we believe that financial concerns should never become a barrier to receiving timely cancer treatment. Through our empanelled partner hospitals, eligible patients can access cervical cancer treatment, cancer surgery, robotic surgery, and minimally invasive procedures under various Central Government, State Government, Defence, and Public Sector healthcare schemes.
Depending on the terms and eligibility of the respective scheme, patients may benefit from cashless hospitalization or reimbursement for approved treatments.
Our dedicated team assists eligible beneficiaries throughout the process, from documentation and approvals to admission and treatment coordination, ensuring a seamless healthcare experience.
We are associated with several government healthcare schemes, including:
Coverage and eligibility are subject to the terms and conditions of the respective healthcare scheme and the empanelled hospital.
Why Choose CUSP Group of Surgeons for Ovarian Cancer Treatment in New Delhi?
The successful treatment of ovarian cancer requires specialised surgical expertise, accurate staging, and coordinated multidisciplinary care. We provide personalised, evidence-based treatment using advanced surgical techniques and comprehensive oncology care to help patients achieve the best possible outcomes.
Patients choose CUSP Surgeons for:
Our goal extends beyond treating cancer. We strive to restore health, improve quality of life, and help every patient return to their daily activities with confidence.
It is critical to profoundly understand what really matters to patients when it comes to disease management and treatment expectations.